Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Ingrid Uhnoo"'
Autor:
Moa Rehn, Ingrid Uhnoo, Sharon Kühlmann-Berenzon, Anders Wallensten, Pär Sparén, Eva Netterlid
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0149857 (2016)
BACKGROUND:The Swedish school-based vaccination programme offers HPV vaccine to girls born ≥1999 in 5-6th grade. In 2012, all counties introduced free-of-charge catch-up vaccination campaigns targeting girls born 1993-1998. Varying vaccine uptake i
Externí odkaz:
https://doaj.org/article/faa2ff75a609449d82235c316eca6ad5
Autor:
Eva Herweijer, Adina L Feldman, Alexander Ploner, Lisen Arnheim-Dahlström, Ingrid Uhnoo, Eva Netterlid, Joakim Dillner, Pär Sparén, Karin Sundström
Publikováno v:
PLoS ONE, Vol 10, Iss 7, p e0134185 (2015)
Concerns have been raised that HPV-vaccination might affect women's cervical screening behavior. We therefore investigated the association between opportunistic HPV-vaccination and attendance after invitation to cervical screening.A cohort of all wom
Externí odkaz:
https://doaj.org/article/2d3ca5d715244d7294c70be8392c81a5
Autor:
Alexander Ploner, Pär Sparén, Eva Herweijer, Karin Sundström, Ingrid Uhnoo, Lisen Arnheim-Dahlström
Publikováno v:
International Journal of Cancer
Human papillomavirus (HPV) types 16/18, included in HPV vaccines, contribute to the majority of cervical cancer, and a substantial proportion of cervical intraepithelial neoplasia (CIN) grades 2/3 or worse (CIN2+/CIN3+) including adenocarcinoma in si
Autor:
Eva Herweijer, Ingrid Uhnoo, Pär Sparén, Alexander Ploner, Christian Dehlendorff, Birgitte Baldur-Felskov, Lisen Arnheim-Dahlström, Susanne K. Kjaer
Publikováno v:
Vaccine. 36(43)
Background Based on immunogenicity studies, a 2 dose HPV vaccination-schedule was recently recommended for girls younger than 15 years. We aimed to investigate the effectiveness of quadrivalent HPV (qHPV) vaccination against CIN2 or worse (CIN2+), by
Autor:
Lisen Arnheim-Dahlström, Eva Herweijer, Alexander Ploner, Favelle Lamb, Karin Sundström, Pär Sparén, Ingrid Uhnoo
Publikováno v:
BMJ Open
Objective To assess incidence of condyloma after two doses of quadrivalent human papillomavirus (qHPV) vaccine, by time since first vaccine dose, in girls and women initiating vaccination before age 20 years. Design Register-based nationwide open coh
Publikováno v:
Vaccine. 36(23)
Background HPV vaccination programs have been introduced in large parts of the world, but monitoring of effectiveness is not routinely performed. Many countries introduced vaccination programs without establishing the baseline of HPV prevalences. We
Autor:
Valeria Alfonsi, Angela Domínguez, Roman Chilbek, Vassiliki Papaevangelou, Vytautas Usonis, Ingrid Uhnoo, Jördis J Ott, Noele P. Nelson, Mira Kojouharova, Emma Byström, Sandro Bonfigli, P. Carrillo-Santisteve, Pier Luigi Lopalco, Denisa Janta, Daniel Shouval, Lara Tavoschi, Michael Edelstein, Ettore Severi, Emmanouil Galanakis
Publikováno v:
The Lancet. Infectious diseases. 17(10)
Summary Most of the European Union (EU) and European Economic Area (EEA) is considered a region of very low hepatitis A virus (HAV) endemicity; however, geographical differences exist. We did a systematic review with the aim of describing seroprevale
Autor:
Eva Netterlid, Moa Rehn, Pär Sparén, Ingrid Uhnoo, Sharon Kühlmann-Berenzon, Anders Wallensten
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0149857 (2016)
PLoS ONE
PLoS ONE
Background The Swedish school-based vaccination programme offers HPV vaccine to girls born >= 1999 in 5-6th grade. In 2012, all counties introduced free-of-charge catch-up vaccination campaigns targeting girls born 1993-1998. Varying vaccine uptake i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2db93c7600af140842ceb3e6f230caae
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-294323
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-294323
Autor:
Joakim Dillner, Lisen Arnheim-Dahlström, Eva Herweijer, Eva Netterlid, Alexander Ploner, Ingrid Uhnoo, Adina L. Feldman, Pär Sparén, Karin Sundström
Publikováno v:
PLoS ONE, Vol 10, Iss 7, p e0134185 (2015)
PLoS ONE
PLoS ONE
Background Concerns have been raised that HPV-vaccination might affect women’s cervical screening behavior. We therefore investigated the association between opportunistic HPV-vaccination and attendance after invitation to cervical screening. Metho
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 23(12)
Background: Organized human papillomavirus (HPV) vaccination was introduced in Sweden in 2012. On-demand vaccination was in effect from 2006 to 2011. We followed the HPV prevalences in Southern Sweden from 2008 to 2013. Methods: Consecutive, anonymiz